Cargando…
Possible mechanisms of action of clarithromycin and its clinical application as a repurposing drug for treating multiple myeloma
Clarithromycin (CAM), a semisynthetic macrolide antibiotic, is a widely used antibacterial drug. Recently, the efficacy of CAM as an add-on drug for treating multiple myeloma (MM) has been noted. Its effect on treating MM has been confirmed in combination chemotherapies that include CAM. However, a...
Autores principales: | Takemori, Nobuo, Ooi, Hong-Kean, Imai, Goro, Hoshino, Kazuo, Saio, Masanao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cancer Intelligence
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498274/ https://www.ncbi.nlm.nih.gov/pubmed/33014130 http://dx.doi.org/10.3332/ecancer.2020.1088 |
Ejemplares similares
-
A novel combination of bortezomib, lenalidomide, and clarithromycin produced stringent complete response in refractory multiple myeloma complicated with diabetes mellitus – clinical significance and possible mechanisms: a case report
por: Takemori, Nobuo, et al.
Publicado: (2018) -
Successful treatment in a case of Propionibacterium acnes-associated sarcoidosis with clarithromycin administration: a case report
por: Takemori, Nobuo, et al.
Publicado: (2014) -
Repurposing Drugs in Oncology (ReDO)—clarithromycin as an anti-cancer agent
por: Van Nuffel, An MT, et al.
Publicado: (2015) -
Complete Remission of Methotrexate-Related Epstein-Barr-Virus-Associated Hodgkin-Like Lymphoma following Withdrawal of MTX Coupled with Clarithromycin Administration
por: Takemori, Nobuo, et al.
Publicado: (2012) -
Lenalidomide and dexamethasone with or without clarithromycin in patients with multiple myeloma ineligible for autologous transplant: a randomized trial
por: Puig, Noemi, et al.
Publicado: (2021)